"This is the first model to generate a purely cerebral microbleed phenotype through a targeted molecular intervention in the adult brain." — Byung Gon Kim, MD, PhD
Groundbreaking Study Links Collagen IV to Brain Microbleeds
Researchers at Ajou University School of Medicine have developed a novel mouse model for cerebral microbleeds, demonstrating that targeted deletion of the Col4a1 gene in adult brain microvascular endothelial cells causes progressive bleeding and cognitive decline.
The study, which also identifies a related genetic risk factor in humans, offers a powerful new platform for understanding and treating a condition linked to dementia and stroke.
A Precise Molecular Trigger
Using CRISPR/Cas9 gene-editing technology, the research team deleted the Col4a1 gene specifically in the microvascular endothelial cells of adult mouse brains. A single intravenous injection of AAV-BR1 delivered the gene-editing machinery, resulting in dozens of microbleeds in the cortex and hippocampus within just three months.
The microbleed burden did not remain static. The number of bleeds increased progressively over six months, and the severity could be precisely scaled by adjusting the viral dose. Electron microscopy revealed that affected blood vessels had thinned basement membranes, a structural weakness directly linked to the loss of collagen IV.
Behavioral and Inflammatory Consequences
The mice developed progressive memory impairment and motor deficits, mirroring symptoms seen in human conditions associated with microbleeds. The study also uncovered a distinct neuroinflammatory pattern:
- Reactive astrocytes spread diffusely beyond the lesion sites, suggesting a widespread brain response.
- Microglial activation, in contrast, remained localized to the immediate area of each bleed.
Human Genetic Link
The findings extend beyond the lab. Analysis of 836 participants from the BICWALZS biobank found that genetic variants in TIMP2—a gene that regulates an enzyme responsible for breaking down collagen IV—were significantly associated with microbleed susceptibility.
These variants increased an individual's risk of cerebral microbleeds by 1.50 to 1.96 times.
A Conserved Mechanism
The study suggests that dysregulated collagen IV homeostasis is a conserved mechanism across species, bridging the gap between a targeted genetic intervention in mice and naturally occurring genetic risk in humans.
"The ability to precisely modulate microbleed burden offers an unprecedented platform for testing future therapies," stated co-corresponding author Byung Gon Kim, MD, PhD.